What risk? Physician group questions FDA view on Testosterone drugs
September 30, 2015
A leading physicians group is questioning claims that testosterone replacement therapy increases the risk of heart disease – contradicting concerns expressed by the Food and Drug Administration.
The statement from the American Association of Clinical Endocrinologists, which heralded a new position paper, comes after the FDA last March asked drug makers to add information on product labeling about the possible increased risk of heart attacks and strokes associated with low testosterone treatments. The drugs are used to boost testosterone levels .
No Comment